Skip to main content
. 2016 Feb 5;11(2):e0148573. doi: 10.1371/journal.pone.0148573

Table 2. Comorbidity and BMI according to region.

Region
United States and Canada Australia and New Zealand Europe Other P-Value
N % (95%CI) N % (95%CI) N % (95%CI) N % (95%CI)
Underweight 37 4.2 (3.0–5.6) 33 4.1 (2.8–5.6) 29 4.7 (3.2–6.5) 1 1.5 (0.0–4.6)
Normal weight 385 43.9~ (40.5–47.1) 461 57.3* (53.9–60.6) 384 62.1* (58.1–66.0) 37 55.2 (43.5–67.2)
Overweight 213 24.3 (21.5–27.0) 183 22.8 (19.8–25.4) 128 20.7 (17.5–24.1) 15 22.4 (12.7–32.8) < .001
Obesity 242 27.6* (24.7–30.7) 127 15.8~ (13.4–18.5) 77 12.5~ (9.9–15.0) 14 20.9 (11.4–31.7)
Back pain 346 39.0* (35.8–42.2) 289 35.4 (32.2–38.6) 200 31.9~ (28.1–35.5) 34 50.0* (38.2–62.7) .003
Depression 354 39.9* (36.6–43.1) 221 27.1~ (24.1–30.2) 158 25.2~ (21.7–28.5) 27 39.7 (29.0–52.2) < .001
Anxiety 309 34.8* (31.5–38.0) 216 26.4~ (23.5–29.6) 148 23.6~ (20.0–27.1) 26 38.2 (27.5–50.0) < .001
Arthritis 160 18.0* (15.4–20.5) 107 13.1 (10.8–15.5) 49 7.8~ (5.7–10.0) 12 17.6 (8.8–27.1) < .001
High blood pressure 148 16.7* (14.3–19.2) 78 9.5 (7.5–11.7) 34 5.4~ (3.6–7.3) 9 13.2 (5.8–22.4) < .001
Anaemia or other blood disease 57 6.4 (5.0–8.0) 53 6.5 (4.8–8.2) 38 6.1 (4.3–8.0) 6 8.8 (2.9–16.2) .851
Ulcer or stomach disease 51 5.7* (4.2–7.4) 24 2.9~ (1.9–4.1) 25 4.0 (2.7–5.5) 8 11.8* (4.4–20.6) .001
Diabetes 36 4.1* (2.8–5.4) 19 2.3 (1.4–3.4) 5 0.8~ (0.2–1.6) 3 4.4 (0.0–10.3) .001
Lung disease 28 3.2 (2.1–4.4) 18 2.2 (1.2–3.3) 13 2.1 (1.1–3.2) 2 2.9 (0.0–7.4) .507
Heart Disease 31 3.5* (2.3–4.8) 12 1.5~ (0.7–2.3) 7 1.1~ (0.3–2.1) 4 5.9* (1.4–11.9) < .001
Cancer 23 2.6 (1.6–3.6) 14 1.7 (0.9–2.6) 12 1.9 (0.8–3.2) 1 1.5 (0.0–4.6) .596
Kidney disease 12 1.4 (0.7–2.1) 5 0.6 (0.1–1.2) 3 0.5 (0.0–1.1) 1 1.5 (0.0–4.5) .221
Liver disease # 6 0.7 (0.2–1.2) 4 0.5 (0.1–1.0) 3 0.5 (0.0–1.1) 2 2.9 (0.0–7.5) .095

* Significantly overrepresented

~ significantly underrepresented

# Chi-square not reliable due to low expected N in >20% of the cells. N = 2366 for BMI and N = 2399 for all comorbidities